Skip to main content
. 2024 May 13;137(11):1316–1323. doi: 10.1097/CM9.0000000000003154

Table 1.

Baseline of healthy donors and UC patients.

Variables HC UCD UCV
Number of patients 300 120 100
Age (years) 51.9 ± 14.8 50.4 ± 14.3 50.1 ± 14.1
Sex (female) 110 (36.7) 43 (35.8) 37 (37.0)
Disease duration (months) 41.2 ± 20.1 36.7 ± 15.7
Smoking 10 8
Drinking 6 7
Disease locations for UC
E1 (proctitis) 12 16
E2 (left-sided colitis) 40 36
E3 (pancolitis) 68 48
Calprotectin (μg/g)
0 month 81.18 ± 36.95 82.02 ± 34.84
6 months 113.93 ± 72.00 100.15 ± 71.84
12 months 136.10 ± 88.86 120.50 ± 89.83
18 months 146.84 ± 97.32

Data were shown as n, mean ± standard deviation, orn (%). HC: Healthy donors; UC: Ulcerative colitis; UCD: Derivation cohort of UC patients; UCV: Verification cohort of UC patients.